This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Duplication 17p11.2 Syndrome
Information about Duplication 17p11.2 Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Duplication 17p11.2 Syndrome
Most recent studies have shown that Duplication 17p11.2 Syndrome shares some biological mechanisms with anxiety-disorders, apnea, autistic-disorder, chromosomal-duplication, congenital-abnormality, congenital-heart-defects, cytogenetic-abnormality, developmental-delay-(disorder), developmental-disabilities, embryonic-mosaic, failure-to-thrive, genomic-instability, hypoplastic-left-heart-syndrome, inattention, multiple-congenital-anomalies, muscle-hypotonia, nervousness, smith-magenis-syndrome.
Among the many pathways, these few ones have gauged particular interests from scientists studying Duplication 17p11.2 Syndrome, and have been seen in publications frequently: Interphase, Localization, Meiosis, Pathogenesis, Social Behavior
Quite a number of genes have been found to play important roles in Duplication 17p11.2 Syndrome, such as AHR, CFD, DSP, ENDOU, EXOSC6, FLCN, INS, LMNB1, MB, MECP2, PAFAH1B1, PTGDR, RAI1, S100A10, SMS, TCF20, YWHAE. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.
Pathways Related to Duplication 17p11.2 Syndrome
This information is being compiled and will come in a future update
| Interphase | Localization | Meiosis |
| Pathogenesis | Social Behavior |